Developmental dysplasia of the hip 1

Summary

Developmental dysplasia of the hip 1 (MONDO:0007729) is a disease and 8 clinical trials. A subtype of developmental dysplasia of the hip — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 8

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	developmental dysplasia of the hip 1
Mondo ID	MONDO:0007729
OMIM	142700
DOID	DOID:0060931
UMLS	C1306065
MedGen	266288
Is cancer (heuristic)	no

Also known as: acetabular dysplasia · DDH1 · developmental dysplasia of the hip 1 · hip dysplasia, congenital

Disease family

This is a subtype of developmental dysplasia of the hip. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary disease › developmental dysplasia of the hip › developmental dysplasia of the hip 1

Related subtypes (3): developmental dysplasia of the hip 2, developmental dysplasia of the hip 3, developmental dysplasia of the hip 4

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 8.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	8

Top trials by phase / activity

NCT	Phase	Status	Title
NCT05869851	Not specified	RECRUITING	Developmental Dysplasia of the Hip: Observation vs. Bracing
NCT06775704	Not specified	RECRUITING	Clinical and Radiological Outcomes of the ROMAX Hip Resurfacing System
NCT07581717	Not specified	RECRUITING	Computer-Assisted Comparison of Hip Socket Volume and Surface Shape After Pediatric Acetabular Osteotomies
NCT03541122	Not specified	UNKNOWN	Three Novel Radiological Indicators for Diagnosis of Adult Acetabular Dysplasia
NCT03578562	Not specified	COMPLETED	Targeted Exercise and Changes in Femoroacetabular Impingement in Symptomatic Patients With Acetabular Retroversion
NCT04006574	Not specified	COMPLETED	Developmental Hip Dysplasia and Physical Therapy
NCT04069507	Not specified	COMPLETED	Healthy Hip Study: Conservative Management for Pre-arthritic Hip Disorders
NCT06037278	Not specified	UNKNOWN	Patient Specific Guides and Surgical Planning for Periacetabular Osteotomy; Post Marketing Evaluation Study